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ResuscitationAbstract ECPR is defined as the rapidly-deployed application of venoarterial extracorporeal
membrane oxygenation, in patients with cardiac arrest, during cardiopulmonary resuscitation
before the return of ROSC. ECPR is one of the most rapidly growing segments of ECLS, and is
becoming more widespread. Consideration for institution of ECPR is given to patients with wit-
nessed arrest, good quality CPR instituted within 5 min of arrest, in whom ROSC does not occur
within 15 min, and who can complete cannulation within 30–60 min. Patients from both inpatient
and out-of-hospital settings are candidates if they meet these criteria. Deep hypothermic cardiac
arrest, such as cold-water drowning, should receive consideration for ECPR even after considerable
duration of arrest. Available outcome data are based on retrospective observation studies, some
with propensity matching, and suggests a higher chance for survival with ECPR. Published out-
comes from ECPR, however, are difficult to interpret, since many centers classify their use of ECLS
after ROSC, in addition to ECLS before ROSC, as ECPR. Both children and adults are candidates
for ECPR, but the experience in children is weighted heavily toward those with a diagnosis of car-
diac disease and arrest occurring within closely monitored units.
 2016 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Extracorporeal cardiopulmonary resuscitation (ECPR) refers
to the use of rapid-deployment venoarterial extracorporealmembrane oxygenation to provide circulatory support during
cardiac arrest, when conventional CPR has failed to provide
return of spontaneous circulation (ROSC) [1,2], or when repet-
itive arrests occur without sustained ROSC. Venoarterial (VA)
ECMO is the required mode of support since cardiac output is
absent or at best inadequate and intermittent. ECPR has
sometimes been used to refer to extracorporeal support of
low cardiac output states following ROSC, but the Extracor-
poreal Life Support Organization (ELSO) does not include
this scenario in its definition of ECPR [2].
ECPR is one of the most rapidly growing segments of
ECLS as reported to the ELSO Registry. In the interval
2012 through 2015 there were 869 neonatal, 1106 pediatric,
and 1337 adult cases reported. This number underrepresents
12 S.A. Conradthe actual number, as a number of centers performing ECPR
are not ELSO centers and are not reporting their data.2. Rationale
Several factors have been associated with survival following
cardiac arrest [3–10]. Included are the initial rhythm and
whether it is shockable, and the presence of comorbidities,
which may be related to initial rhythm. The time to initiation
of external chest compressions, and the adequacy of those
compressions are both important factors. The time to defibril-
lation in the presence of a shockable rhythm and the time to
return of spontaneous circulation (ROSC) are also major
determinants.
ECPR has the potential to modify some of these factors,
although data are lacking to demonstrate any direct influence.
The institution of support provides definitive and immediate
return of circulation, albeit not spontaneous, thereby provid-
ing adequate organ perfusion not possible with CPR.
Improved perfusion of the myocardium may allow success at
defibrillation, or elimination of myocardial hypoxemia that
may have led to non-shockable rhythms, thereby allowing
return of myocardial function. External circulation can permit
rapid institution of hypothermia during the resuscitation
phase, greatly reducing exposure to higher temperatures at
the time of reperfusion.
3. Patient selection
In the adult population, there is sufficient experience with
ECPR to provide guidance for selecting patients who may ben-
efit [11]. As new data accumulate, it is likely that criteria for
consideration will change. One of the difficult decisions to
make is when to consider conventional resuscitation measures
inadequate and an indication to initiate ECPR. Too early
implementation would lead to application in many patients
who would have recovered conventionally, whereas too late
implementation could lead to application beyond the period
of reversibility. The rate of ROSC decreases with time, with
half or more of patients recovering from in-hospital and out-
of-hospital cardiac arrest within 10–15 min, and the great
majority within 20 min [12,13]. The target to initiation of sup-
port would be ideally 30 min, but no more than 60 min, from
onset of conventional resuscitation. Beginning the decision-
making within 10 min and completing by 15 min would allow
identification of patients with low chance of ROSC with con-
ventional means and allow for ECPR within the allowable
time limits [11].
The arrest should be witnessed, and the duration of no-flow
prior to resuscitation efforts should be less than 5 min. Good-
quality CPR should have been provided at all times, which
may best be performed with properly adjusted mechanical
compression devices. Additional considerations include the
presence of comorbidities, especially cardiovascular, and the
pre-arrest functional status. Patients sustaining cardiac arrest
in both the inpatient and out-of-hospital setting should be
considered.
ECPR is now the treatment of choice for deep hypothermic
(<20 C) cardiac arrest refractory to conventional resuscita-
tion efforts. Variance on the times to conventional CPR and
time to ECPR can be afforded these patients, since experiencesuggests good outcomes with therapy delayed to as long as
226 min [14].
4. Technical considerations
As a rapidly-deployed procedure, ECPR programs benefit
from simplified pre-primed circuits positioned in a strategic
location, trained individuals to perform percutaneous or surgi-
cal cannulation, and a cross-discipline organization structure
supported by defined protocols.
5. Extracorporeal circuit
Centrifugal pump systems with hollow-fiber membrane oxy-
genators have numerous advantages that make them most suit-
able for ECPR. These components can be quickly primed and
have reasonably small priming volumes. The centrifugal pump
is afterload-dependent, and circuit rupture is non-existent
when properly assembled and operated, eliminating the need
for pre- and post-pump pressure monitoring. The pump pro-
vides a controlled inlet pressure, allowing augmented venous
return without the need for gravity-facilitated hydrostatic pres-
sure, allowing the pump to be positioned close to the patient.
Hollow-fiber membrane oxygenators prime quickly without
residual deadspace.
The size of the extracorporeal circuit depends on patient
size. Circuits with ¼00 tubing size are used for pediatric circuits
for body weights up to about 15 kg. Larger children and adults
are managed with ⅜00 tubing size circuits. Centrifugal pumps
currently are available in one size with ⅜00 inlet and outlet
ports, and require downsizing for pediatric circuits. Membrane
oxygenators are available in adult (⅜00 connector), and pedi-
atric (¼00 connector) sizes, with some manufacturers providing
a neonatal size. The membrane oxygenator should have a rated
flow at least 1.5 times the expected maximum flow for the
patient.
The use of pre-primed circuits eliminates any time lost to
priming at the time of cardiac arrest. Circuits primed with crys-
talloid alone (free of glucose, protein and blood products) have
been shown to be infection free for 14 days [15] and up to
30 days [16]. It is likely that longer durations of storage are
safe, but data are lacking. A potential approach to prolonged
storage is to sample the circuit for bacterial antigens or culture
at intervals and discard the circuit if contamination is found.
Although microporous hollow-fiber membrane oxygenators
lose some function after pre-priming [17], modern nanoporous
‘‘plasma tight” hollow-fiber membrane oxygenators do not
appear to lose any functional capacity when stored for 2 weeks
[18], and there does not appear to be any leaching of plasticiz-
ers into the prime [19].
The introduction of small-footprint, portable, integrated
ECLS systems has streamlined the initiation of ECLS, and
has demonstrated functionality during transport [20] and in-
hospital support [21].
6. Cannulation
The cannulation sites for arteriovenous support in the adult
depend on the circumstances surrounding resuscitation.
Patients in the emergency department or hospital ward who
are not post-op cardiac patients will usually undergo
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tion is frequently used when one clinician is performing both
cannulations. When two clinicians are available, then each
can cannulate on a different side without interference, reducing
the time to cannulation. An advantage of the femoral site is
that it does not interfere with external chest compressions.
The choice between percutaneous and surgical approaches
to the femoral vessels is largely dependent on the skill and pref-
erence of the clinician. Percutaneous cannulation can be per-
formed quickly, but in the absence of spontaneous
circulation, identification of vessel location and size is prob-
lematic, and the failure rate may be higher. The use of ultra-
sound may mitigate these issues, but adds to the procedure
time. In settings where percutaneous cannulation is limited
to surgeons who may not be in the department, the placement
of small vascular catheters by non-surgeons can reduce the
time to complete cannulation with the larger ECMO cannulae
[22]. Surgical cannulation allows ready identification of vessel
anatomy, but limits the procedure to surgeons who may not be
readily available. This approach is typically limited to institu-
tions with full-time availability of surgical staff. The surgical
approach is also the only option for failed percutaneous
cannulation.
Cannula size is chosen to provide an extracorporeal flow of
4–5 L/min, sufficient to maintain full circulatory support. The
venous cannula must be large enough to accommodate flow
at pressure gradients of 50 mmHg, typically 24–28 Fr. Arterial
cannulae are necessarily smaller due to femoral artery size,
and range from 16 to 19 Fr.When placed surgically, the femoral
artery is ligated, and a 6–8 Fr. antegrade cannulamust be added
to the reinfusion limb of the circuit to prevent limb ischemia and
loss. An antegrade cannula is commonly required after percuta-
neous cannulation, but can also be placed percutaneously.
Postoperative cardiac patients in the intensive care unit
may be candidates for central cannulation. The incision and
sternum can be reopened, with cannulation of the right atrium
and aorta. Support can continue through the open chest, and if
recovery is adequate, decannulation can be performed. If
support will be of a longer duration, conversion to peripheral
cannulation is desirable to reduce infectious and bleeding com-
plications. Central cannulation outside the operating suite
requires prior planning with adequate equipment and
resources available in the unit.
7. Complications
As with extracorporeal support for any indication, ECPR is
associated with the risk of complications ranging from minor
to fatal. ECPR is instituted as rapid-deployment venoarterial
ECMO, with the risk of vascular injury leading to failure to
cannulate or to bleeding complications. Failure to maintain
adequate flow can lead to suboptimal support and non-
survival. Intracranial hemorrhage is a serious complication
which can greatly decrease chance of survival. Reperfusion
injury can contribute to multiple organ failure, sepsis and neu-
rologic injury.
8. Outcomes
The use of ECPR in adults is increasing significantly, with
more patients reported to the ELSO Registry in the past3 years than all previous years combined. The reported cumu-
lative survival is 29% [23]. Although not high, it is likely that
the majority of the patients would not have survived otherwise.
Survival in single center studies is reported to be higher.
In a meta-analysis of 11 observational studies of adult
ECPR in the inpatient setting, the overall survival to discharge
was 40% [24]. The definition in this study included post-ROSC
ECLS. When restricted to pre-ROSC ECLS, the survival was
48%, with a pre-ECLS time of 40 min. Shorter pre-ECLS time
was associated with 1.9 odds of survival compared to the
whole group. A prospective observational study of ECPR
compared with conventional CPR using propensity matching
in 172 patients with in-hospital arrest revealed a higher sur-
vival to discharge, as well as 30-day and 1-year survival [25].
In a recent retrospective analysis of conventional CPR com-
pared with ECPR in 353 patients with in-hospital cardiac
arrest, ECPR was associated with improved short-term and
long-term survival [26].
Deep hypothermic cardiac arrest managed with ECPR
appears to have a better prognosis than standard extracorpo-
real rewarming, preventing death from cardiopulmonary com-
plications associated with lung reperfusion [27]. In this series of
59 patients, 25 treated with ECPR survived, a 6.6-fold increase
over standard rewarming.
The application of ECPR in the pediatric population is
dominated by its use in patients with congenital heart disease
in the inpatient setting. A study of children and infants with
heart disease based on the ELSO Registry analyzing 492
patients demonstrated a 42% survival, with predictors for
mortality including single ventricle physiology, prior Stage 1-
type procedure, and extreme acidosis [28]. It is unclear if this
cohort included patients who may have received post-ROSC
support that was classified as ECPR, as the ELSO Registry
does not enforce this definition. A report from the Hospital
for Sick Children on 80 children receiving ECPR indicated a
30% survival with favorable neurologic outcome [29]. Nearly
90% of this group had a cardiac diagnosis. A survival rate
of 73% with grossly normal neurologic function was reported
in a cohort of 32 patients in a retrospective study, in a group of
patients of whom 82% were cardiac patients [30]. In a cohort
of 31 patients with predominantly cardiac disease, 23% sur-
vival with good function was reported [31]. This group found
no relationship between duration of CPR prior to ECPR
and outcome.
In a mixed group of 54 pediatric inpatients with both
cardiac and non-cardiac causes analyzed retrospectively, a sur-
vival of 46% was reported [32]. The survival rate for cardiac
and non-cardiac causes were approximately equal, with 44%
of non-cardiac causes surviving.9. Ethical and cultural considerations
Introduction of extracorporeal circulation into resuscitation
from cardiac arrest poses new potential issues of an ethical nat-
ure. These issues relate to decisions on both initiation and ter-
mination of support. The basic principles of autonomy,
beneficence, non-maleficence and justice become more com-
plex during extracorporeal resuscitation efforts. The patient
usually has not provided any information about his or her
right to refuse treatment, and decisions are usually made in
urgency by the healthcare team. While data are accumulating
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still don’t have clear guidance. We usually don’t have the abil-
ity to identify futility prior to ECPR, and we have a technology
that can artificially support life until terminated. As a resource
limited in availability, we are unable to provide ECPR equally
to all patients who may potentially benefit.
While we now rely on guidance from the application of con-
ventional CPR to help with decisions on introducing ECPR,
new challenges with ECPR are emerging. For example, there
is the potential for irreversible neurologic injury to develop
while being supported on ECPR. In countries that do not rec-
ognize brain death, this can pose ethical dilemmas. There is
also the possibility of a patient recovering neurologic function
following ECPR, but without recovery of cardiac function or
candidacy for transplantation. Withdrawal of support in this
case is now a very different scenario since the patient can par-
ticipate in decision making [33], but was not a participant
when ECPR was initiated.10. Summary
ECPR is defined as the application of venoarterial extracorpo-
real membrane oxygenation, in patients with cardiac arrest,
during cardiopulmonary resuscitation before the return of
ROSC. The technique is technically challenging but feasible.
Consideration for institution of ECPR is given to patients with
witnessed arrest, good quality CPR instituted within 5 min of
arrest, in whom ROSC does not occur within 15 min, and
who can complete cannulation within 30–60 min. Available
outcome data are based on retrospective observation studies,
some with propensity matching, and suggest a higher chance
for survival with ECPR. Published outcomes from ECPR,
however, are difficult to interpret, since many centers classify
their use of ECLS after ROSC, in addition to ECLS before
ROSC, as ECPR. Both children and adults are candidates
for ECPR, but the experience in children is weighted heavily
toward those with a diagnosis of cardiac disease and arrest
occurring within closely monitored units.
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